Arthritis is a very common disease but it is not well understood yet. Arthritis is basically joint pain or joint disease. Basically Juvenile idiopathic arthritis or juvenile rheumatoid arthritis is the common inflammatory arthritis of childhood and Common symptom of Juvenile idiopathic arthritis is musculoskeletal pain. Juvenile idiopathic arthritis is mostly affected to under age 17 children.
This report contains market size and forecasts of Juvenile Idiopathic Arthritis Treatment in Global, including the following market information:
Global Juvenile Idiopathic Arthritis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Juvenile Idiopathic Arthritis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Juvenile Idiopathic Arthritis Treatment include Johnson & Johnson, Novartis, Bristol-Myers Squibb, Zydus Cadila, Takeda, Roche and Latona Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Juvenile Idiopathic Arthritis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Juvenile Idiopathic Arthritis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Juvenile Idiopathic Arthritis Treatment Market Segment Percentages, by Type, 2021 (%)
Surgical Treatment
Drug Treatment
Global Juvenile Idiopathic Arthritis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Juvenile Idiopathic Arthritis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Diagnostic Laboratories
Global Juvenile Idiopathic Arthritis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Juvenile Idiopathic Arthritis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Juvenile Idiopathic Arthritis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Juvenile Idiopathic Arthritis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Novartis
Bristol-Myers Squibb
Zydus Cadila
Takeda
Roche
Latona Life Sciences